Level Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-775
Closed -$120K 73
2023
Q4
$120K Hold
775
0.06% 78
2023
Q3
$116K Hold
775
0.06% 73
2023
Q2
$104K Hold
775
0.06% 76
2023
Q1
$124K Sell
775
-6
-0.8% -$917 0.07% 67
2022
Q4
$126K Buy
781
+6
+0.8% +$920 0.08% 61
2022
Q3
$104K Hold
775
0.08% 68
2022
Q2
$119K Buy
775
+600
+343% +$91.7K 0.09% 65
2022
Q1
$28K Hold
175
0.02% 114
2021
Q4
$24K Buy
+175
New +$20.7K 0.02% 126

Other funds holding ABBV

Level Financial Advisors's ABBV Position: Q1 2024 in Review

Level Financial Advisors sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 775 shares — an estimated $120K sold.

Level Financial Advisors first reported a position in ABBV in Q4 2021 and held it in 9 quarters. The position peaked at $126K in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Level Financial Advisors reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Level Financial Advisors sold 775 AbbVie shares in Q1 2024, an estimated $120K.
  • Level Financial Advisors first reported a position in AbbVie in Q4 2021 and held it in 9 quarters.
  • Level Financial Advisors's AbbVie position peaked at $126K in Q4 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Level Financial Advisors's 13F filing for Q1 2024, filed 19 Apr 2024.